Search Tags

Funding Opportunity


Covid-19

Purdue University is rapidly responding to the COVID-19 pandemic by focusing existing research efforts, launching new research efforts, providing support to our larger community of health care workers, and providing just-in-time information to enable the continuation of critical on-campus research. Faculty from 19 different research groups are ramping up their COVID-19 research with projects ranging from understanding the infection process, development of diagnostic tools, and development of therapeutics and inhibitors. Faculty and staff have mobilized 11 large scale efforts to respond to the COVID-19 pandemic to provide direct support to rural communities and local healthcare providers by donating and developing PPE. There are currently 17 pending proposals for new research related to COVID-19, focused on understanding the spread, patient recovery, impact on infrastructure, detection methods, treatments. All research support personnel and services have responded to the call to action by developing various COVID-19 related forms and websites to collect and share up-to-date information such as funding opportunities, critical on-campus research continuity information, federal agency information, and rapid proposal submission. There is a growing list of faculty (over 30) that have self-identified as having expertise applicable to understanding, preventing, treating, and overcoming the COVID-19 pandemic.


Active COVID-19 Research

# Research Title Investigator
1 Investigating the COVID-19 infection processes. W. Andy Tao
2 Developing diagnostic tools for COVID-19. Tamara Kinzer-Ursem
3 Design of a sensing device for the rapid detection of COVID-19 from saliva. Lia Stanciu-Gregory
4 Development of point-of-care diagnostic test for COVID-19 infection. Jacqueline Linnes
5 Understanding and potentially inhibiting the causative agent of COVID-19 by raising antibodies against the viral proteins that can act to neutralize the virus and prevent viral entry. Robert Stahelin
6 Screening inhibitors found to work on other lipid-enveloped viruses. Robert Stahelin
7 Discovery and development of therapeutics and diagnostics. Joe Davisson
8 Studying an anti-Ebolavirus compound template that has demonstrated to have efficacy against feline corona virus.
9 Testing potential antiviral agents Richard Kuhn
10 Working with BSL-2 agents related to the virus and cloning, expression and purification of COVID-19 proteins Richard Kuhn
11 High-performance computational research on Corona virus proteins. May have future relevance to drug and/or vaccine development related to COVID-19 Jorge Rodriguez
12 Testing an anti-COVID-19 strategy to block virus entry to cells. Designed an approach by which cells are able to produce a protein to block viral proteins involved in cell recognition Ruben Claudio
13 Designing and synthesizing organic compounds that would function as inhibitor for COVID-19 enzymes which are required for replication of the virus Arun Ghosh
14 Development of new combination adjuvants that have the potential to be used in vaccines against SARS-CoV2 Harm HogenEsch
15 Developing paper-based biosensor devices for diagnosing COVID-19 at the point-of-care Mohit Verma
16 Development of molecular sensing systems and methods for detection of the virus that causes COVID-19. Utilizing optical sensing modalities to detect minute quantities of virus Cagri Savran

Purdue University